Biotransformation and Bioactive Molecules
Biotransformation and Bioactive Molecules
Research team at the Catalonia Institute for Advanced Chemistry-CSIC
Institute for Advanced Chemistry of Catalonia
About
Biotransformation and Bioactive Molecules (BBM) research team at the Catalonia Institute for Advanced Chemistry CSIC
CARBAZYME’s Team 2018
CARBAZYME’s TEAM (2016)
Participants in the Biotransformation and Bioactive Molecules Research Group. June 2009 (From left to right: (standing: Dr. Jesús Joglar, Dr. Jordi Bujons, Prof. Dr. Pere Clapés, Dr. Xavier Garrabou (PhD Student), sitting Ms Mariana Gutierrez (PhD Student), Ms Alda Lisa Concia (PhD Student), Ms Livia Gómez (PhD Student) and Anna Szekrényi (PhD Student)
Participants in the Biotransformation and Bioactive Molecules Research Group (From left to right: (standing: Dr Jordi Bujons, Dr. Jesús Joglar, Prof. Dr Pere Clapés, Dr Ramon Crehuet, Ms Aurora Jimenez (PhD Student), Ms Alda Lisa (PhD Student); siiting Dr Jose Castillo (Post-doc in France), Dr. Xavier Garrabou (PhD Student), Dr Jordi Calveras (Post-doc in Japan), Ms Mariana Gutierrez (PhD Student) and Ms Livia Gómez (PhD Student)
Prof. Dr. Pere Clapés
Prof. Dr. Pere Clapés
Full Professor at CSIC (Spanish Research Council) Catalonia Institute for Advanced Chemistry (IQAC)
Chemist specialized in biocatalysis and biotransformation in organic asymmetric synthesis of bioactive molecules. He’s published over 100 scientific papers and patents in the field of biocatalysis. He is currently head of the Biotransformation and Bioactive Molecules Group were he conducts research on the exploitation of biocatalysts in asymmetric carbon-carbon bond formation as a means to rapidly create chiral structures of high complexity to produce novel compounds for bioactivity testing. The research in close cooperation with the other participants of the group includes cascade chemoenzymatic synthesis, analysis, purification, computational models, and biological evaluation of products. Prof. Dr. Clapés product research is focused on cancer, particularly in metastasis, and the prevention of the metabolic syndrome, with particular focus on the control of blood sugar.
The lab at the Catalonia Institute for Advanced Chemistry
-
Archives
- August 2008 (1)
-
Categories
-
RSS
Entries RSS
Comments RSS
